#151580

Anti-ENTPD1 [AC2]

Cat. #151580

Anti-ENTPD1 [AC2]

Cat. #: 151580

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-5 days

Target: Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1, CD39)

Class: Monoclonal

Application: FACS ; IF ; IP ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Martin Rowe

Institute: University of Birmingham

Primary Citation: Rowe et al. 1982. Int J Cancer. 29(4):373-81. PMID: 6282762.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ENTPD1 [AC2]
  • Research fields: Cell biology;Immunology;Neurobiology;Tissue-specific biology
  • Clone: AC2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 70-100 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IF ; IP ; WB
  • Description: Monoclonal antibody which binds ENTPD1, and reacts with Epstein Barr lymphoblastoid cell lines. ACE2 reacted consistently with all Epstein Barr virus lymphoblastoid cell line (EB-LCL) tested, with a subpopulation of cells in some but not all EB virus genome-positive Burkitt lymphoma lines, but with none of a range of EB virus genome-negative cell lines of lymphoma or leukaemia origin.
  • Immunogen: EBV-transformed human B lymphoblastoid cell line
  • Immunogen uniprot id: O75356
  • Isotype: IgG1
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: EBV-transformed human B lymphoblastoid cell line as positive control

Target Details

  • Target: Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1, CD39)
  • Molecular weight: 70-100 kDa
  • Tissue cell line specificity: EBV-transformed human B lymphoblastoid cell line
  • Target background: ENTPD1 is a transmembrane glycoprotein of apparent molecular weight of 70-100 kD that has an Ectonucleoside triphosphate diphosphohydrolase-1 (NTPDase-1, ecto-apyrase) activity hydrolysing the alpha- and beta- phosphate residues of extracellular ATP or ADP. In haematopoietic tissues, it is primarily expressed on activated B, T and NK cells. It is also expressed on some endothelial cells and cardiac neurons, and helps regulate platelet activation, vascular inflammation, and cardiac norepinephrine release.

Applications

  • Application: FACS ; IF ; IP ; WB
  • Application notes: Recommended Concentrations: FACS: 1ug/5x10^5 cells Immunofluorescence on acetone-fixed frozen sections or cell smears: 1-2ug/ml Western blot (ECL): 0.2ug/ml

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Shipping at 4° C

References

  • Rowe et al. 1982. Int J Cancer. 29(4):373-81. PMID: 6282762.